Randall Moreadith, Chief Scientific Officer at Serina Therapeutics, Inc. (SER), sold 6,500 shares at $2.50 ($16K) on 2026-01-14, disclosed to the SEC on 2026-01-14.
Open-market sale of $16k SER by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.50 | 5,416 | $14K | 83.3% |
| 2 | $2.50 | 1,084 | $3K | 16.7% |
| Total | $2.50 avg | 6,500 | $16K | 100% |
| Filing → |
| SER | SELL | 2026-02-03 | $20K | — | Filing → |
| SER | SELL | 2026-01-29 | $23K | — | Filing → |
| SER | SELL | 2026-01-23 | $7K | — | Filing → |